Amareg Berlin Brackenheim Latina Livron Malta Münster Toride USA Wolfratshausen Wülfing Loxxess

Executive Board Sites Sales

Digital Art Museum [DAM]

Solid dosage forms Liquid and semi-solid dosage forms Sterile dosage forms Hormone Preparations Cytostatic Agents

Clinical Supplies

Contract Manufacturing

07.09.10

Haupt Pharma at the ICSE - Contract manufacturing and development at the highest level confirmed by successful completion of an FDA audit

06.09.10

Flexible and fast blister line for packaging cytostatics and immunosuppressives

27.08.10

Hans-Christian Semmler has resigned from his position as Chief Executive Officer of Haupt Pharma AG

Dr. Robert Fritsch is taking over as the sole Managing Director of Haupt Pharma Brackenheim GmbH

24.09.09

With immediate effect Dr. Robert Fritsch is the sole Managing Director of Haupt Pharma Brackenheim GmbH. After an extensive period of preparation for succeeding Mr Karl-Heinz Renner he was appointed the second Managing Director on October 1, 2007.

After working successfully for us for many years, Mr Karl-Heinz Renner has left the company. Under his guidance the packaging company in Brackenheim developed into the market leader in the packing of tablets, dragées and capsules in blisters.